Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Brief Reports

HbA1c Levels Are Significantly Lower in Early and Late Pregnancy

  1. Lene R. Nielsen, MD1,
  2. Pia Ekbom, MD, PHD1,
  3. Peter Damm, MD, DMSC2,
  4. Charlotte Glümer, MD3,
  5. Merete M. Frandsen3,
  6. Dorte M. Jensen, MD, PHD4 and
  7. Elisabeth R. Mathiesen, MD, DMSC1
  1. 1Department of Endocrinology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
  2. 2Department of Obstetrics, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
  3. 3Steno Diabetes Center, Copenhagen, Denmark
  4. 4Department of Endocrinology, Odense University Hospital, Odense, Denmark
  1. Address correspondence and reprint requests to Elisabeth Mathiesen, Department of Endocrinology, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: em{at}rh.dk
Diabetes Care 2004 May; 27(5): 1200-1201. https://doi.org/10.2337/diacare.27.5.1200
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading
  • DCCT, Diabetes Control and Complications Trial
  • OGTT, oral glucose tolerance test

Strict glycemic control is essential to minimize the maternal and fetal morbidity and mortality of pregnancies complicated by diabetes (1–3). In addition to home blood glucose measurement, which may not always reflect the true average blood glucose level (4), HbA1c is a useful parameter in metabolic regulation (5–8). Thus, supplementation with HbA1c, as is common outside pregnancy, seems appropriate.

Before pregnancy, the target for metabolic control in women with diabetes is HbA1c values near the normal range (9). However, the upper normal range of HbA1c during normal pregnancy is only sparsely investigated with different methods (10), mainly in late pregnancy (5,6,11,12), and reference ranges are generally established from the nonpregnant state (4). Increased third-trimester HbA1c levels are associated with an increased risk of preeclampsia (3,13), macrosomia (1), and stillbirth (2), leading to speculations that the target for HbA1c in pregnancy should be even lower than outside pregnancy to prevent adverse events.

There is a need to establish the reference range of HbA1c during normal pregnancy with an internationally recognized Diabetes Control and Complications Trial (DCCT)-aligned method. In this study, we evaluated the normal upper range of HbA1c in early and late pregnancy.

RESEARCH DESIGN AND METHODS

From our antenatal clinic, we randomly selected 100 healthy pregnant women without previous gestational diabetes (early pregnancy group). All subjects had a random capillary blood glucose level <7.0 mmol/l at their first antenatal visit at approximately week 14 (range 8–17), and none developed gestational diabetes. A selective screening based on risk factors for gestational diabetes was used (14).

A late pregnancy group was established of 98 healthy pregnant women in week 33 (range 28–37), who, as part of another study (14), had a normal 75-g oral glucose tolerance test (OGTT). HbA1c was measured on the same day as the OGTT.

The nonpregnant control group consisted of 145 healthy women aged 30 years who were investigated as a part of the population survey Inter 99 (15). All had a normal OGTT.

All women were Nordic Caucasians and had HbA1c measured in microsamples from the earlobe with the high-performance liquid chromatography DCCT-aligned method (Tosch Automated Glycohemoglobin Analyzer; Tosch Bioscience, Minato, Japan) at the Steno Diabetes Center (8) (normal range 4.1–6.4%, interassay precision coefficient of variation 3.5%). A normal OGTT was defined as a 2-h OGTT value <7.8 mmol/l (16). Random blood glucose measurements were performed using a HemoCue device (Hemocue, Ängelholm, Sweden), which has a coefficient of variation in pregnant women of 2.8–3.7% (17,18).

For calculation of BMI, prepregnancy height and weight were used in the pregnant women. The protocol was approved by the local ethical committee.

Statistical analysis

Data are given as means ± SD. A trend test was used to compare the three groups. When the trend test was significant, unpaired Student’s t tests were used for comparison between the groups using the Bonferroni correction to allow for multiple comparisons. P < 0.05 is considered significant. HbA1c was regarded as normally distributed. Normal range was calculated as means ± 2 SD.

RESULTS

HbA1c was significantly decreased early in pregnancy and further decreased in late pregnancy compared with age-matched nonpregnant women (Table 1). The normal range of HbA1c was 4.7–6.3% in nonpregnant women, 4.5–5.7% in early pregnancy, and 4.4–5.6% in late pregnancy. To exclude that the differences in HbA1c were due to differences in BMI between the groups, women with BMI >25 kg/m2 were excluded from all the groups, leaving 106 nonpregnant subjects, 87 early pregnancy subjects, and 85 late pregnancy subjects. Average HbA1c did not change significantly (control 5.5 ± 0.4, early pregnancy 5.1 ± 0.3, and late pregnancy 5.0 ± 0.3%; P for trend <0.001), whereas BMI was comparable (21.7 ± 2.0, 21.6 ± 1.7, and 21.5 ± 1.9 kg/m2; P = NS).

CONCLUSIONS

In carefully selected women without diabetes and using a cross-sectional design, we found that HbA1c was lower early in pregnancy and further decreased in late pregnancy compared with age-matched nonpregnant women using a DCCT-aligned method. A decrease of the upper normal limit of HbA1c from 6.3% before pregnancy to 5.6% in the third trimester of pregnancy is of significant clinical importance when defining the reference range for HbA1c during pregnancy in women with diabetes.

Our findings are in agreement with O’Kane et al. (6), who studied 493 healthy women with a DCCT-aligned method, mainly in the third trimester, and with Hartland et al. (5), who investigated 267 pregnant Caucasian and 249 Asian subjects using a latex-enhanced turbidimetric immunoassay. However, nonpregnant women were not included for comparison in these two studies. Our study included a sufficient number of women to detect significant differences, and the importance of using a DCCT-aligned HbA1c method has been addressed in a consensus statement (8).

In late pregnancy, all women in our study had a documented normal glucose tolerance test. This might explain why we found a further reduction in HbA1c in late pregnancy in contrast to others (5).

During normal pregnancy, a decrease in fasting blood glucose occurs early in pregnancy, mainly between weeks 6 and 10, and is sustained during the remaining part of pregnancy (19). New erythrocytes formed will therefore be exposed to a lower time-averaged glucose concentration than those of nonpregnant women, and the degree of glycosylation might therefore be less (12). In addition, the erythrocyte lifespan is likely to be decreased in pregnancy, hence also reducing the HbA1c value (20–22). The Hb level was not measured in this study, and a possible role of anemia could not be accounted for.

Our study, which included nonpregnant, early pregnant, and late pregnant women, demonstrated a decline of the upper normal level of HbA1c from 6.3 to 5.7% in early pregnancy and to 5.6% in the third trimester of pregnancy, indicating a reduction of HbA1c during normal pregnancy that is of clinical importance when defining the goal for HbA1c during pregnancy complicated with diabetes.

View this table:
  • View inline
  • View popup
Table 1—

HbA1c in normal, early, and late pregnancy compared with age-matched nonpregnant women without diabetes

Footnotes

  • C.G. holds stocks in and receives grant support from Novo Nordisk.

    • Accepted January 20, 2003.
    • Received January 19, 2004.
  • DIABETES CARE

References

  1. ↵
    Evers IM, de Valk HW, Mol BWJ, ter Braak EWMT, Visser GHA: Macrosomia despite good glycaemic control in type I diabetic pregnancy: results of a nationwide study in the Netherlands. Diabetologia 45:1484–1489, 2002
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Lauenborg J, Mathiesen ER, Ovesen P, Westergaard JG, Ekbom P, Molsted-Pedersen L, Damm P: Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 26:1385–1389, 2003
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Ekbom P, Damm P, Nogaard K, Clausen P, Feldt-Rasmussen U, Feldt-Rasmussen B, Nielsen LH, Molsted-Pedersen L, Mathiesen ER: Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type I diabetes. Diabetologia 43:927–931, 2000
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Kyne-Grzebalski D, Wood L, Marshall SM, Taylor R: Episodic hyperglycaemia in pregnant women with well-controlled type 1 diabetes mellitus: a major potential factor underlying macrosomia (Editorial). Diabet Med 16:621–622, 1999
    OpenUrlCrossRefPubMed
  5. ↵
    Hartland AJ, Smith JM, Clark PMS, Webber J, Chowdhury T, Dunne F: Establishing trimester- and ethnic group-related reference ranges for fructosamine and HbA1c in non-diabetic pregnant women. Ann Clin Biochem 36:235–237, 1999
    OpenUrlPubMed
  6. ↵
    O’Kane MJ, Lynch PLM, Moles KW, Magee SE: Determination of a diabetes control and complications trial-aligned HbA1c reference range in pregnancy. Clin Chim Acta 311:157–159, 2001
    OpenUrlCrossRefPubMedWeb of Science
  7. Kilpatrick ES: Glycated haemoglobin in the year 2000. J Clin Pathol53:335–339, 2000
  8. ↵
    Marshall SM, Barth JH: Standardization of HbA1c measurements: a consensus statement (Review). Diabet Med 17:5–6, 2000
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    American Diabetes Association: Preconception care of women with diabetes (Position Statement). Diabetes Care 23:S65–S68, 2000
    OpenUrlPubMed
  10. ↵
    Worth R, Potter JM, Drury J, Fraser RB, Cullen DR: Glycosylated haemoglobin in normal pregnancy: a longitudinal study with two independent methods. Diabetologia 28:76–79, 1985
    OpenUrlPubMedWeb of Science
  11. ↵
    Parentoni LS, de Faria EC, Bartelega MJLF, Moda VMS, Facin ACC, Castilho LN: Glycated hemoglobin reference limits obtained by high performance liquid chromatography in adults and pregnant women. Clin Chim Acta 274:105–109, 1998
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Lind T, Cheyne GA: Effect of normal pregnancy upon the glycosylated haemoglobins. Br J Obstet Gynaecol 86:210–213, 1979
    OpenUrlPubMedWeb of Science
  13. ↵
    Hiilesmaa V, Suhonen L, Teramo K: Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43:1534–1539, 2000
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Jensen DM, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Ovesen P, Damm P: Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol 189:1383–1388, 2003
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Glumer C, Jørgensen T, Borch-Johnsen K: Prevalences of diabetes and impaired glucose regulation in a Danish population. Diabetes Care 26:2335–2340, 2003
    OpenUrlAbstract/FREE Full Text
  16. ↵
    World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
  17. ↵
    Carr SR, Slocum J, Tefft L, Haydon B, Carpenter M: Precision of office-based blood glucose meters in screening for gestational diabetes. Am J Obstet Gynecol 173:1267–1272, 1995
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Åberg A: Gestational Diabetes: Screening, Diagnosis and Prognosis. Lund, Sweden, Studenterlitteratur, 2001
  19. ↵
    Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E, Lee YJ, Holmes L, Simpson JL, Metzger B: Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the Diabetes in Early Pregnancy Study. Metabolism 47:1140–1144, 1998
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Lurie S: Age distrubution of erythrocyte population in late pregnancy. Gynecol Obstet Invest 30:147–149, 1990
    OpenUrlPubMedWeb of Science
  21. Lurie S, Danon D: Life span of erythrocytes in late pregnancy. Obstet Gynecol 80:123–126, 1992
    OpenUrlPubMedWeb of Science
  22. ↵
    Lurie S: Density distribution of erythrocytes in class A2 (insulin requiring) gestational diabetes. Arch Gynecol Obstet 258:65–68, 1996
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Diabetes Care: 27 (5)

In this Issue

May 2004, 27(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
HbA1c Levels Are Significantly Lower in Early and Late Pregnancy
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
HbA1c Levels Are Significantly Lower in Early and Late Pregnancy
Lene R. Nielsen, Pia Ekbom, Peter Damm, Charlotte Glümer, Merete M. Frandsen, Dorte M. Jensen, Elisabeth R. Mathiesen
Diabetes Care May 2004, 27 (5) 1200-1201; DOI: 10.2337/diacare.27.5.1200

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

HbA1c Levels Are Significantly Lower in Early and Late Pregnancy
Lene R. Nielsen, Pia Ekbom, Peter Damm, Charlotte Glümer, Merete M. Frandsen, Dorte M. Jensen, Elisabeth R. Mathiesen
Diabetes Care May 2004, 27 (5) 1200-1201; DOI: 10.2337/diacare.27.5.1200
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Combination Therapy With Fenofibrate and Rosiglitazone Paradoxically Lowers Serum HDL Cholesterol
  • β-Cell Transplantation Restores Metabolic Control and Quality of Life in a Patient With Subcutaneous Insulin Resistance
  • Hematocrit and the Incidence of Type 2 Diabetes in the Pima Indians
Show more Brief Reports

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.